6F7Q
Human Butyrylcholinesterase complexed with N-Propargyliperidines
Summary for 6F7Q
Entry DOI | 10.2210/pdb6f7q/pdb |
Descriptor | Cholinesterase, SULFATE ION, CHLORIDE ION, ... (12 entities in total) |
Functional Keywords | alzheimer disease ad butyrylcholinesterase n-propargyliperidines, hydrolase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 126208.40 |
Authors | Coquelle, N.,Knez, D.,Colletier, J.P.,Gobec, S. (deposition date: 2017-12-11, release date: 2018-09-05, Last modification date: 2024-05-01) |
Primary citation | Knez, D.,Coquelle, N.,Pislar, A.,Zakelj, S.,Jukic, M.,Sova, M.,Mravljak, J.,Nachon, F.,Brazzolotto, X.,Kos, J.,Colletier, J.P.,Gobec, S. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. Eur.J.Med.Chem., 156:598-617, 2018 Cited by PubMed: 30031971DOI: 10.1016/j.ejmech.2018.07.033 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.6 Å) |
Structure validation
Download full validation report